Plain-English translation of NCT06285539 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Netherlands
Testing effectiveness
Sponsor
UMC Utrecht
Collaborators
Alfasigma S.p.A., ReumaNederland
Enrollment target
~60 participants
Started
March 2024
Primary completion
December 2026
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anne Karien Marijnissen, Dr
UMC Utrecht
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.